1. Type I hyperprolinemia: genotype/phenotype correlations
- Author
-
Valérie Drouin-Garraud, Simona Orcesi, Audrey Guilmatre, Caroline Espil-Taris, Lionel Van Maldergem, Luisa Bonafé, Dominique Campion, David Valle, Thierry Frebourg, Vassili Valayannopoulos, Eric Le Galloudec, Patricia Blanchet, Cyril Mignot, Vincent des Portes, Bernard Echenne, Christine Ioos, Claudia Izzi, Hélène Maurey, Gabriella Di Rosa, Solenn Legallic, Jodi D. Hoffman, Alexandra Afenjar, Alice Goldenberg, Gary Steel, Alecia Willis, Agathe Roubertie, Agnès Guët, Génétique médicale et fonctionnelle du cancer et des maladies neuropsychiatriques, Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Estonian Genome and Medicine, University of Tartu, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Department of Medical and Surgical Pediatrics, University Hospital, Department of Genetics, CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Laboratoire sur le langage, le cerveau et la cognition (L2C2), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Department of Neuro-Metabolism, CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Regional Hospital, Tufts Medical Center, Università degli Studi di Brescia = University of Brescia (UniBs), Fondation 'Neurological Institute C. Mondino ', Université de Lausanne = University of Lausanne (UNIL), Beauvais Hospital, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Raymond-Poincaré Hospital, CHU Pitié-Salpêtrière [AP-HP], Hôpital Arnaud de Villeneuve [CHRU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Gui de Chauliac [CHU Montpellier], Service de neuropédiatrie, CHU Hôpital, École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Università degli Studi di Brescia [Brescia], Université de Lausanne (UNIL), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Gui de Chauliac, and Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
- Subjects
Adult ,Male ,Adolescent ,Proline ,Mutation, Missense ,Biology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Proline dehydrogenase ,Genotype ,Proline Oxidase ,Genetics ,medicine ,Humans ,Missense mutation ,Allele ,Child ,Amino Acid Metabolism, Inborn Errors ,Alleles ,Genetic Association Studies ,Genetics (clinical) ,030304 developmental biology ,0303 health sciences ,Mutation ,Proline oxidase ,[SCCO.NEUR]Cognitive science/Neuroscience ,Haplotype ,Infant ,Life Sciences ,medicine.disease ,Molecular biology ,3. Good health ,Case-Control Studies ,Child, Preschool ,Hyperprolinemia ,PRODH, type I hyperprolinemia, 22q11, POX enzymatic activity ,Female ,030217 neurology & neurosurgery - Abstract
International audience; Type I hyperprolinemia (HPI) is an autosomal recessive disorder associated with cognitive and psychiatric troubles, caused by alterations of the Proline Dehydrogenase gene (PRODH) at 22q11. HPI results from PRODH deletion and/or missense mutations reducing proline oxidase (POX) activity. The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients. 8/14 variants occurred at polymorphic frequency in 114 controls. POX activity was determined for 6 novel mutations and 2 haplotypes. The c.1331G>A, p.G444D allele has a drastic effect whereas the c.23C>T, p.P8L allele and the c.[56C>A; 172G>A], p.[Q19P; A58T] haplotype result in a moderate decrease in activity. Among the 19 HPI patients, 10 had a predicted residual activity A, p.T275N allele, which has no detrimental effect on activity but whose frequency in controls is only 3%. Our results suggest that PRODH mutations lead to a decreased POX activity or affect other biological parameters causing hyperprolinemia.
- Published
- 2010
- Full Text
- View/download PDF